ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,859Medicare Part D Prescriptions Filled, Including Refills

Rank: 234 out of 5176

$909K Total Retail Price of All Prescriptions

Rank: 333 out of 5176

561 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 561 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 561 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 13,878 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 738 704 1 1
WARFARIN SODIUM 620 620 2 13
LEVOTHYROXINE SODIUM 548 508 3 4
FUROSEMIDE 480 452 4 8
METOPROLOL TARTRATE 455 444 5 6
AMLODIPINE BESYLATE 359 350 6 2
DONEPEZIL HCL 350 350 7 28
METFORMIN HCL 311 311 8 7
DIOVAN HCT 268 257 9 39
OMEPRAZOLE 265 261 10 3
NAMENDA 236 236 11 47
CITALOPRAM HBR 228 226 12 31
LISINOPRIL 176 165 13 5
NYSTATIN-TRIAMCINOLONE 174 168 14 142
ATORVASTATIN CALCIUM 174 164 14 9
DIGOXIN 174 172 14 56
DIOVAN 170 139 17 19
SERTRALINE HCL 164 153 18 30
ATENOLOL 163 153 19 12
LOSARTAN POTASSIUM 162 134 20 14
JANUVIA 150 136 21 25
METOPROLOL SUCCINATE 150 149 21 11
ZOLPIDEM TARTRATE 142 132 23 17
FAMOTIDINE 140 140 24 58
CARVEDILOL 137 132 25 24
GABAPENTIN 132 125 26 21
POTASSIUM CHLORIDE 132 132 26 34
TRAMADOL HCL 131 131 28 40
CLOPIDOGREL 129 120 29 26
LOSARTAN-HYDROCHLOROTHIAZIDE 126 125 30 35
ENALAPRIL MALEATE 122 122 31 22
PREDNISONE 121 107 32 52
PLAVIX 120 113 33 29
ALENDRONATE SODIUM 115 101 34 18
QUETIAPINE FUMARATE 110 101 35 75
TAMSULOSIN HCL 106 101 36 20
ACTOS 102 91 37 85
LEVETIRACETAM 101 101 38 92
LOVASTATIN 100 100 39 46
LACTULOSE 100 100 39 87
CRESTOR 87 68 41 15
OXYCODONE-ACETAMINOPHEN 86 75 S2 42 101
HALOPERIDOL 86 86 42 145
NEXIUM 81 80 44 16
MIRTAZAPINE 79 79 45 45
HYDROCHLOROTHIAZIDE 75 74 46 10
CIPROFLOXACIN HCL 72 65 47 84
EXFORGE 72 71 47 126
CARBIDOPA-LEVODOPA 71 71 49 98
SANTYL 68 64 50 124
LANTUS 68 51 50 66
ISOSORBIDE MONONITRATE ER 67 67 52 44
ECONAZOLE NITRATE 65 29 53 340
AMLODIPINE BESYLATE-BENAZEPRIL 63 60 54 55
TRAZODONE HCL 62 60 55 71
PAROXETINE HCL 61 60 56 93
RISPERIDONE 61 61 56 78
JANUMET 60 53 58 77
ALBUTEROL SULFATE 59 58 59 99
TRAVATAN Z 57 57 60 234
OXCARBAZEPINE 57 37 60 379
SEROQUEL 55 52 62 166
LANSOPRAZOLE 54 34 63 113
SPIRIVA 54 52 63 54
AMIODARONE HCL 53 53 65 281
KLOR-CON M20 53 52 65 129
ZETIA 53 44 65 68
CYMBALTA 52 50 68 90
OLANZAPINE 50 49 69 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.